CompletedPhase 2NCT01528787
Study of AR-13324 in Patients With Elevated Intraocular Pressure
Studying NON RARE IN EUROPE: Primary adult open-angle glaucoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Aerie Pharmaceuticals
- Principal Investigator
- Theresa Heah, MDAerie Pharmaceuticals, Inc.
- Intervention
- AR-13324 Ophthalmic Solution 0.01%(drug)
- Enrollment
- 85 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2012 – 2012
Study locations (11)
- Aesthetic Eye Care Institute, Newport Beach, California, United States
- Robert Noecker, M.D., M.B.A., Fairfield, Connecticut, United States
- Coastal Research Associates, LLC, Roswell, Georgia, United States
- Heart of America Eye Care, P.A., Shawnee Mission, Kansas, United States
- Comprehensive Eye Care, St Louis, Missouri, United States
- Rochester Ophthalmology Group, Rochester, New York, United States
- The Eye Institute, Tulsa, Oklahoma, United States
- Wills Eye Hospital, Philadelphia, Pennsylvania, United States
- Univ Eye Surgeons, Maryville Ctr., Maryville, Tennessee, United States
- Texan Eye, Austin, Texas, United States
- Medical Center Ophthalmology Associates, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01528787 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT07354516Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular HypertensionQlaris Bio, Inc.
- RECRUITINGNCT07303257Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical OptionsHospices Civils de Lyon
- RECRUITINGPHASE1, PHASE2NCT06921317GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle GlaucomaIVIEW Therapeutics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT07082816Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionAlcon Research
- ACTIVE NOT RECRUITINGPHASE2NCT06030193Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)Qlaris Bio, Inc.
- RECRUITINGNANCT06682962Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle GlaucomaOkuvision GmbH
- RECRUITINGPHASE4NCT06848946Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneGlaukos Corporation
- RECRUITINGNCT06691555Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) ShuntDavinci LTD
See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma →